Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCHP With or Without Estrogen Deprivation in HR+, HER2+ Breast Cancer
NCT02003209Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Feb 2014
- Primary completion
- Oct 2016
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of goserelin in breast cancer, sponsored by National Cancer Institute. Started Feb 2014; status: completed.
02
Drugs
goserelin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02003209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02003209.